Trial
NCT01969123
Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
FORUM Pharmaceuticals Inc
Collaborators
—
Condition
Alzheimer's Disease
Intervention
Drug: EVP-6124
Why stopped
Study has been suspended due to clinical hold.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-03